+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Search Bar & Filters

Found 2 Actively Recruiting clinical trials

E

Actively Recruiting

Researchers are studying the effectiveness and safety of Dolutegravir combined with Lamivudine compared to other antiretroviral regimens in pregnant women who have HIV-1 and have not received prior treatment. The study focuses on how well these treatments reduce the viral load in mothers and prevent HIV transmission to their newborns. It also looks at maternal side effects, birth outcomes, immune system changes, and resistance to treatment during pregnancy. Participants receive one of two drug regimens Dolutegravir plus Lamivudine taken once daily as a single tablet, or Dolutegravir combined with either TenofovirEmtricitabine or TenofovirLamivudine daily tablets. The study is randomized and open-label, meaning participants are assigned to groups by chance without placebo, and treatment is observed openly. Treatment continues through pregnancy until six months after delivery, with monitoring of viral load and other health indicators. During the study, participants will have regular visits for blood tests measuring viral load, immune cell counts, drug resistance, and safety labs. The babies will be tested at birth, six weeks, and six months to check for HIV infection. Researchers will track maternal weight gain, pregnancy outcomes, side effects, and whether the women need to change their treatment before delivery. The total involvement lasts about 14 months, depending on when participants join during pregnancy.

Age: 15Years +FEMALEPhase 4
10 locations
F

Actively Recruiting

Healthy Volunteer

Chagas disease is a common infection in Argentina, especially in urban areas, but most people are unaware they have it. Diagnosing chronic Chagas disease usually requires multiple blood tests done at specialized labs, which can delay diagnosis and treatment. Rapid diagnostic tests RDTs could improve timely detection at local health centers, but they need evaluation in real-world settings to confirm their accuracy and usefulness. This research will observe how well two commercially available RDTs perform when used directly with blood samples at public health sites in Argentina. The study will compare these tests to standard laboratory methods and evaluate different blood sample types. It will also assess the ease of use, cost-effectiveness, and how well these tests help increase diagnosis access in different healthcare settings. Participants will include people over 10 months old such as pregnant women, blood donors, transplant recipients, and those suspected of chronic infection. Blood samples will be collected for rapid tests and standard lab tests, with clinical and epidemiological data recorded. The study will measure test accuracy, agreement between tests, usability, and cost factors. The research will run for 24 months and aims to improve diagnostic strategies for chronic Chagas disease in Argentina.

Age: 10Months +All Genders
4 locations